Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Accumulated Expenses (2023 - 2025)

Guardian Pharmacy Services' Accumulated Expenses history spans 3 years, with the latest figure at $15.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 4.28% year-over-year to $15.0 million; the TTM value through Dec 2025 reached $15.0 million, up 4.28%, while the annual FY2025 figure was $15.0 million, 4.28% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $15.0 million at Guardian Pharmacy Services, down from $15.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $17.3 million in Q2 2025 and bottomed at $10.5 million in Q1 2025.
  • The 3-year median for Accumulated Expenses is $15.0 million (2025), against an average of $14.9 million.
  • The largest annual shift saw Accumulated Expenses fell 14.92% in 2024 before it increased 14.25% in 2025.
  • A 3-year view of Accumulated Expenses shows it stood at $17.0 million in 2023, then dropped by 14.92% to $14.4 million in 2024, then grew by 4.28% to $15.0 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Accumulated Expenses are $15.0 million (Q4 2025), $15.9 million (Q3 2025), and $17.3 million (Q2 2025).